S.164: Advancing Education on Biosimilars Act of 2021

Read the bill

About This Bill

This bill was introduced in the 117th Congress
This bill is primarily about health
Introduced Feb. 2, 2021
Latest Major Action April 23, 2021
See the one similar bills introduced in other congresses.

Bill Summary

Advancing Education on Biosimilars Act of 2021 This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 3 statements associated with S.164.

See statements

Bill Actions

Date	Description
April 20, 2021	Presented to President.
April 14, 2021	On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 8 (Roll no. 101).
April 14, 2021	Considered as unfinished business.
April 14, 2021	Considered under suspension of the rules.
April 14, 2021	On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 8 (Roll no. 101). (text: CR H1754)
April 14, 2021	Considered as unfinished business. (consideration: CR H1783-1784)
April 14, 2021	Considered under suspension of the rules. (consideration: CR H1754-1755)
April 14, 2021	Motion to reconsider laid on the table Agreed to without objection.
April 14, 2021	At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
April 14, 2021	DEBATE - The House proceeded with forty minutes of debate on S. 164.
April 14, 2021	Mr. Pallone moved to suspend the rules and pass the bill.
March 8, 2021	Held at the desk.
March 8, 2021	Received in the House.
March 8, 2021	Message on Senate action sent to the House.
March 3, 2021	Passed the Senate Passed Senate without amendment by Unanimous Consent. (consideration: CR S1021; text: CR S1021)
March 3, 2021	Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S1021; text: CR S1021)
March 3, 2021	Passed the Senate Passed Senate without amendment by Unanimous Consent.
March 3, 2021	Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
March 3, 2021	Passed the Senate Passed Senate without amendment by Unanimous Consent. (text: CR S1021)
March 3, 2021	Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S1021)
Feb. 2, 2021	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb. 2, 2021	Introduced in the Senate by Margaret Hassan (D-N.H.)

Legislators

Bills

Statements

Lobbying

Travel

About This Bill

Bill Sponsor

Bill Cosponsor

Bill Versions

Bill Summary

What Lawmakers Are Saying About This Bill

Passed the Senate

Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S1021; text: CR S1021)

Passed the Senate

Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.

Passed the Senate

Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S1021)

Introduced in the Senate by Margaret Hassan (D-N.H.)